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Abstract Lactoferrin is considered as a part of the innate
immune system that plays a crucial role in preventing bac-
terial growth, mostly via an iron sequestration mechanism.
Recent data show that bovine lactoferrin prevents late-onset
sepsis in preterm very low birth weight neonates by serving
as an iron chelator for some bacterial strains; thus, it is very
important to control the iron saturation level during diet
supplementation. An accurate estimation of lactoferrin iron
saturation is essential not only because of its clinical appli-
cations but also for a wide range of biochemical experi-
ments. A comprehensive method for the quantification of
iron saturation in lactoferrin preparations was developed to
obtain a calibration curve enabling the determination of iron
saturation levels relying exclusively on the defined ratio of
absorbances at 280 and 466 nm (A280/466). To achieve this
goal, selected techniques such as spectrophotometry, ELISA,
and ICP-MS were combined. The ability to obtain samples of
lactoferrin with determination of its iron content in a simple
and fast way has been proven to be very useful. Furthermore, a
similar approach could easily be implemented to facilitate the
determination of iron saturation level for other metalloproteins
in which metal binding results in the appearance of a distinct
band in the visible part of the spectrum.
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Introduction
Lactoferrin (Lf), a protein being a member of the transferrin
family, is highly abundant in colostrum and milk, but is also
present in other extracellular excretions. This glycoprotein
bears remarkable resemblance to transferrin—both proteins
have a molecular weight of about 80 kDa and their structure
comprises two lobes, each one capable of binding one ferric
ion. The most important difference is lactoferrin possessing
the ability to bind iron more tightly (binding constants of
∼1022–1024 and 1020–1021 M−1 for lactoferrin and transfer-
rin, respectively, were reported) [1–3] and retain it at much
lower pH values [4] than serotransferrin. Another
lactoferrin-specific feature is a highly basic N-terminal re-
gion that allows interaction with negatively charged mole-
cules such as lipopolysaccharide [5] or glycosaminoglycans
[6]. Those two properties grant its ability to act as an
antimicrobial agent and affecting immune response by bind-
ing to receptors on target cells.
Lactoferrin undergoes glycosylation in various species,
but the number and location of glycosylation sites vary
depending on the protein origin. Human lactoferrin has three
potential N-glycosylation sites (Asn137, Asn478, and
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Asn623); cow, goat, and sheep lactoferrin has five (Asn233,
Asn281, Asn368, Asn476, and Ans545) [7]. Folding of
human lactoferrin does not depend on the number and
location of bound glycan chains, and the role of glycosyla-
tion has not been elucidated so far. Several studies revealed
that deglycosylation of human lactoferrin does not affect the
binding of iron and other molecules, but decreases the
proteolytic resistance of lactoferrin [8]. However, it has been
reported that the glycosylation of camel lactoferrin influ-
ences the protein structure and iron binding mode within the
cleft of the C-lobe. Supposedly, localization of the glyco-
sylation site in the C-lobe inhibits the domain closer and
weakens iron binding [9]. Lactoferrin is a basic protein with
an isoelectric point of 8.7. To our knowledge, there are no
data showing the influence of glycosylation or iron satura-
tion on protein pI value. Basing on results reported for
transferrin glycoforms (pentasialotransferrin, pI=5.2;
tetrasialotransferrin, pI=5.4; trisialotransferrin, pI=5.6; and
disialotransferrin, pI=5.7) [10], it should be expected that
glycosylation should decrease the observed protein isoelec-
tric point as a consequence of increasing the number of
glycosylated arginine residues. Noticeable changes of the pI
values should be anticipated upon saturation of latoferrin with
iron (pI of 5.2 and 5.6 were reported for Fe2-Tf and Fe-Tf,
respectively) [11]. The natural microheterogeneity of
lactoferrin (different glycosylation status and iron satu-
ration levels) makes lactoferrin isoforms difficult to
separate.
Since nearly all living organisms need iron to live, iron
scavengers—such as lactoferrin—might have a static effect
on the growth of microorganisms in the gastrointestinal
tract. The antimicrobial activity of lactoferrin has been fre-
quently reported—its influence on bacterial, viral, protozo-
an, and fungal pathogen growth has been numerously
reviewed [12–14]. However, very little attention has been
paid to the iron saturation level of lactoferrin used in those
studies. The iron content of lactoferrin preparations is an
aspect somewhat neglected in the literature—only a few
groups investigated the more accurate determination of the
percentage saturation of lactoferrin with ferric ions and
differentiation between the effects of the apo and holo forms
on the studied pathogen species or target human cells. It has
been shown that iron-free and iron-saturated lactoferrin af-
fects human enterocytes in a different way [15, 16]. Fur-
thermore, apolactoferrin has been described as more potent
in reducing the growth of numerous bacterial strains
[17–20].
Neither accurate determination of Lf iron content nor the
preparation of apo- and hololactoferrin is a trivial issue. The
simplest way of calculating the iron content in the prepara-
tion is based on spectrophotometric measurement. Total
protein concentration can be determined using the absorp-
tion coefficient at 280 nm, while the concentration of the
holo form can be estimated by employing molar absorption
coefficient at 466 nm. The band in the visible part of
spectrum with maximum approx. 470 nm is characteristic
of iron-saturated lactoferrin. In the literature, several differ-
ent absorption coefficients were described for both apo- and
hololactoferrin; some of them are presented in electronic
supplementary material (ESM) Table S1. However, the
application of absorption coefficients to calculate the
protein concentration is limited to the situation when
only the apo or the holo form is present in solution.
When the preparation is a mixture of both forms, the
use of this method can lead to substantial deviations. To
improve the accuracy of protein content determination,
some groups applied ELISA [21], the method of Lowry
[22], or the method of Dumas using a nitrogen–protein
analyzer [23, 24]. Calculation of the iron content using the
spectrophotometric method faces a problem related with the
coexistence of diferric and monoferric lactoferrin forms.
About 47–58 % of human serum transferrin is monoferric,
while 16–52 % is in the apo form and differric transferrin
accounts for 2–31 % depending on the origin of the blood
samples [25]. To our knowledge, there are no analogous data
reported for lactoferrin. Human lactoferrin was found to be
saturated in 20 % [26], while bovine lactoferrin is saturated
with iron in 15–19% [27, 28]. The similarity of proteins of the
lactoferrin family suggests that a significant percentage of
lactoferrin may be in the monoferric form. The iron content
of lactoferrin preparations can be accurately determined using
inductively coupled plasma–mass spectrometry (ICP-MS)
[29, 30] or optical emission spectrometry [31, 32] as well as
atomic absorption spectrometry techniques. Recently, the
commercially available iron/TIBC kit was also applied
for the determination of iron saturation levels in apo-
and holotransferrin, with no data for lactoferrin avail-
able yet [33].
The most convenient and easily accessible way of
determining the iron content in a lactoferrin preparation,
which is valuable not only for biomedical research but
also for drug development sector, would be the usage of
the ratio of absorbances at 280 and 466 nm. Such
approach has been described several times in the litera-
ture. In the early 1980s, the value of 27–28 was pro-
posed for the bovine lactoferrin fully saturated with iron
[34], while quite recently, the value of 22 was
suggested for fully saturated non-glycosylated human
serum transferrin [35]. However, there is no information
about using this parameter for lactoferrin only partially
saturated with iron. To address the aforementioned prob-
lems, we have combined several techniques such as
spectrophotometry, ELISA, and ICP-MS in order to
prepare the calibration curve enabling determination of
the iron saturation level of bovine lactoferrin relying
solely on the A280/466 ratio.
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Materials and methods
Materials
Bovine lactoferrin was purchased from DMV International
(estimated purity, 95 %; Veghel, the Netherlands) and the
reference sample from Sigma-Aldrich Co. (≥85 % pure; St.
Louis, MO, USA) and stored at 4 °C. Citric acid, acetic acid,
and sodium chloride were analytical grade reagents supplied
by POCH S.A. (Gliwice, Poland). Bovine β-lactoglobulin,
lysozyme from chicken egg, ribonuclease A from bovine
pancreas, bovine serum albumin, ferritin from equine spleen
type I (saline solution), β-galactosidase from Escherichia
coli, and other chemicals were of analytical grade and pur-
chased from Sigma-Aldrich Co. Buffers and reagents in all
experiments were prepared using Milli-Q water.
Electrophoresis: SDS-PAGE
The abundance of different protein species was examined
using 10 % polyacrylamide gel electrophoresis under dena-
turing conditions [36]. Gels were stained with Coomassie
Brilliant Blue and documented using GelDoc-It™ 310 Im-
aging System (Upland, CA, USA).
Preparation of bovine apo- and hololactoferrins
Lactoferrin supplied by the manufacturers was used without
further purification. For apolactoferrin, preparation containing
50 mg/mL protein was dissolved in water and dialyzed exten-
sively against 100 mM citrate buffer for 24 h, followed by
dialysis against distilled water for 24 h [37]. Temperature
(4 and 20 °C) and buffer pH (2.0–5.0) were modified in order
to monitor their impact on iron desaturation. Iron saturation
was calculated based on the A280/A466 ratio according to the
calibration curve presented in “Results and discussion.” We
define the iron saturation level of lactoferrin as the percentage
of iron-binding sites occupied by ferric ions assuming that
2 mol of iron(III) ions is bound per 1 mol of protein. Thus,
the given values refer to the percentage of differic lactoferrin.
For some of these samples, the ICP-MS and ELISA tests were
carried out and were used to prepare a calibration curve.
Hololactoferrin was prepared by the reaction of 50 mg/mL
lactoferrin solution in 50 mM Tris–HCl, 150 mM NaCl
(pH 7.4) with ferric nitrate salt in the presence of
nitrilotriacetic acid (NTA) as well as different concentrations
of sodium bicarbonate [24]. After incubation, excess iron was
removed by dialysis against the same buffer solution without
ferric salts for 24 h and against water for another 24 h. Various
incubation times, temperatures, as well as ratios of Lf/Fe/NTA
were employed to examine their effect on iron saturation
efficiency; detailed conditions are depicted in the captions of
figures.
Resaturation of apolactoferrin
The apolactoferrin prepared by dialyzing a sample of the orig-
inal lactoferrin to citrate buffer (100 mM, pH 2.0, 3.0, and 4.0)
at room temperature as described above was resaturated with
iron ions in order to evaluate its chelation. Lf was incubated
(1 h, room temperature) with ferric nitrate salt in the presence of
nitrilotriacetic acid at a Lf/Fe/NTA ratio of 1:4:4.
FPLC procedures
The chromatographic system ÄKTA Purifier 10 (GE
Healthcare, Life Sciences), with an injection loop of
50 μL, fraction collector FRAC-901, and UV/VIS (Monitor
UV-900, GE Pharmacia) as well as conductivity (Monitor
pH/C-900, GE Pharmacia) detectors were applied for pro-
tein separation.
Size exclusion chromatography
A Superdex 200 10/300 GL column (10×300-mm ID,
13-μm particle diameter; Tricorn, GE Healthcare Life Sci-
ence) was equilibrated with phosphate buffer (50 mM,
150 mM NaCl, pH 8.4) at a flow rate of 0.5 mL/min and
was kept at 20 °C. All buffers before use in fast protein
liquid chromatography (FPLC) system were degassed and
filtered through a 0.45-μm filter. Calibration of the column
was achieved by using the following molecular mass markers:
ribonuclease A (13.7 kDa), lysozyme (14.3 kDa),
β-lactoglobulin (35.0 kDa), bovine serum albumin (66 kDa),
ferritin (440 kDa), andβ-galactosidase (465 kDa). The sample
of lactoferrin (DMV International or Sigma-Aldrich) was
diluted in the same buffer, filtered through a 0.22-μm mem-
brane filter, and subsequently loaded into a 50-μl loop and
injected into the column. After sample introduction, the pro-
tein was eluted with the aforementioned buffer. Detection
wavelength was set at 280 nm.
Ion exchange chromatography
A MonoS 5/50 GL column (5×50-mm ID, 10-μm particle
diameter; Tricorn, GE Healthcare, Life Science) was used
for CIEX separation. Various conditions of the separation
(different eluent compositions, pH, gradients, and flow
rates) were applied to achieve the separation of three forms
of lactoferrin: apo-, holo-, and monoferric. Finally, to obtain
a homogenous Lf preparation, solutions of 50 mM potassi-
um phosphate (pH 7.5), A, and 50 mM potassium phos-
phate, 1.5 M potassium chloride (pH 7.5), B, were used as
eluents. The column was equilibrated at 1 mL/min with
buffer A. Separation was monitored spectrophotometrically
at 280 nm as well as by conductivity measurement, while
the temperature of the column was kept at 21 °C. Lactoferrin
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solution (10 mg/mL; DMV International) was diluted in
buffer A, filtered through a 0.22-μm membrane filter, and
subsequently loaded into a 1-mL loop and injected into the
column. After sample application, the column was washed
with 5 column volumes at a flow rate of 2 mL/min with A.
Lactoferrin adsorbed on the column was eluted with a step
gradient—from 0 to 25 % B and from 25 to 75 % B at a flow
rate of 1 mL/min—after which the column was washed with
5 column volumes with B. Fractions of 1 mL were collected
during the chromatographic run. As a result of several
purifications, no separation of peaks corresponding to the
different iron-saturated lactoferrins was achieved. In order
to discriminate the effect of glycosylation from those of iron
saturation on protein separation, the fraction that was pooled
from the central part of the major peak identified as a non-
glycosylated form of Lf (Fig. 2) was lyophilized and mod-
ified to obtain both apo- and hololactoferrins, as described
in “Preparation of bovine apo- and hololactoferrins.” The
prepared non-glycosylated apo- and hololactoferrin samples
were loaded separately into a 50-μl loop, injected into the
MonoS column, and chromatographic separation was
performed by utilizing the procedure described above.
A MonoQ 5/50 GL separation column was also used for
AEX separation. Our attempts—involving usage of various
conditions for the ion exchange chromatographic method—to
isolate peaks corresponding to different iron-saturated
lactoferrins were unsuccessful (results not shown).
Spectroscopic measurements
UV/VIS spectra were recorded using a Perkin Elmer Lambda
35 spectrophotometer, with photometric accuracy ±0.010 A
(measured for potassium dichromate) and photometric repro-
ducibility <0.001 A. Samples were appropriately diluted when
necessary to obtain absorbance below 1. The obtained
A280/A466 ratios were subsequently used to determine the iron
saturation of lactoferrin preparations applying the calibration
curve presented in “Results and discussion.”Measurements of
circular dichroism (CD) spectra were conducted with a JASCO
J-710 spectropolarimeter (JASCO, Tokyo, Japan). The range
of measurement (250–187 nm) was selected after sample test
scan. Measurements were carried out for lactoferrin purchased
from DMV International and Sigma-Aldrich as well as the
apo- and hololactoferrins obtained by purification (using cation
exchange chromatography) and iron saturation/desaturation of
commercially available products. All samples were prepared in
50 mM Tris–HCl buffer (pH 7.4).
Enzyme-linked immunosorbent assay
ELISAwas conducted using bovine lactoferrin (bLf) ELISA
kit (Alpha Diagnostic International, San Antonio, TX,
USA). A standard curve was prepared with the supplied
bLf standard with concentration ranging from 10 to
140 ng/mL. The tested samples were diluted 500,000 and
1,000,000 times in a sample diluent buffer and the test
performed according to the manufacturer’s protocol. ELISA
plates were read using Tecan Infinite 200 Reader plate at
450 nm to determine Lf concentration. Measurement at
630 nm was performed for background subtraction. Tests
were performed for the samples with the lowest A280/A466
ratio as well as partially saturated lactoferrin samples, with
the results used for calibration curve preparation.
Inductively coupled plasma–mass spectrometry
The total iron content in lactoferrin was measured by the
application of ICP-MS. For ICP-MS measurements,
lactoferrin samples with the lowest values of A280/A466 and
partially saturated lactoferrin preparations were chosen. Prior
to the determination of iron content, 100 μL of the samples
was diluted with 6 mL of concentrated HNO3 and mineralized
using Microwave Digestion System: Multiwave 3000 (Anton
Paar) by employing 1,000-W power, 15-min ramp, followed
by a 20-min hold with a rate of 0.4 bar s−1 up to 50 bar, at
213–230 °C. Iron concentration was determined in these
samples with the ICP-MS technique performed with an ELAN
DRCe Perkin Elmer spectrometer, employing the following
conditions: plasma gas (Ar), 15 L min−1; Rf power, 1,270 W;
nebulizer gas flow, 0.99 L min−1; auxiliary gas flow,
1.20 L min−1. The 57Fe isotope was used for the quantification
of iron content in samples.
Results and discussion
Purity check
In order to verify the information provided by the manufac-
turers concerning the purity of lactoferrin preparations, two
complementary techniques were exploited. First, denaturing
electrophoresis in polyacrylamide gel was performed, yield-
ing one distinct band of molecular weight approx. 80 kDa
(Fig. 1a) for the DMV International and Sigma lactoferrin
samples. Few lower-molecular-weight bands were also
detected for both commercially available lactoferrin prepa-
rations. The presence of these bands was previously
reported [38] and identified as degraded forms of lactoferrin.
The purity of lactoferrin supplied by DMV International was
densitometrically estimated as over 90 % and was higher
than the purity of Lf preparation purchased from Sigma-
Aldrich. The second approach involved the chromatograph-
ic separation of lactoferrin preparations on the gel filtration
column. In order to overcome the problem of the unspecific
binding of protein to the dextran resin observed when
performing separation at pH ranging from 7.0 to 8.0, a
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higher value of pH 8.4 and increased salt concentration were
used during the final size exclusion chromatography (SEC)
separation. The main peak corresponding to the protein of
molecular weight of approx. 80 kDa along with the minor
peaks from smaller proteins were observed, which is con-
sistent with electrophoretic analysis (Fig. 1b). Both ap-
proaches confirmed the high purity of DMV lactoferrin
preparation. Therefore, DMV International’s preparation
was used for further experiments; no additional purification
procedures were performed in the following experiments.
The starting preparation of lactoferrin from DMV Inter-
national contains approx. 10 % of holo-lactoferrin; there-
fore, the analytical cation exchange chromatography using
MonoS was performed to separate apolactoferrin from its
holo form according to the protocol described by Makino
and Nishimura [39]. We observed that Lf was consistently
eluted as one asymmetric peak. As a result of the first
purification step, the major peak was observed at 0.63 M
KCl and corresponds to a non-glycosylated form of Lf,
whereas the small shoulder eluted at 0.53 M KCl contains
protein with an N-linked glycan at the Asn281 position
(Fig. 2a). Our results proved previous findings that N-
linked glycosylation of bovine lactoferrin affects its elution
from MonoS [40], but we have not been able to reproduce
the observation of Makino and Nishimura [39] that apo- and
iron-saturated lactoferrins are eluted at different positions
from a MonoS column that allows their separation. To
obtain homogeneous lactoferrin preparation, the MonoS
elution fraction containing the non-glycosylated variant of
lactoferrin was pooled, iron-saturated/desaturated, and
subjected to re-chromatography (Fig. 2c).
MonoS chromatography of the non-glycosylated iron-
saturated bovine lactoferrin (>65 %) showed no significant
changes in the elution profile when compared with its apo form
(<2%), indicating that iron saturation does not affect bovine Lf
binding and elution Lf from the MonoS column. During the
second chromatographic step, homogenous apo- and
hololactoferrins consistently eluted at 0.76 M KCl in a single
symmetric peak. Our results are in line with earlier reports that
apo- and iron-saturated human Lf bind equally well to anionic
ligands and exhibit the same profile on MonoS [8, 41, 42]. It is
possible that an extraordinary charge asymmetry encountered
Fig. 1 a SDS polyacrylamide gel electrophoresis of DMV International
(left) and Sigma-Aldrich (right) bovine lactoferrin preparations. Lanes
were loaded with 2.5, 5, and 10 μg of protein. Central lane was loaded
with a molecular weight marker (two bands of 70 and 100 kDa denoted
on the electropherogram). b SEC elution profile of DMV International
lactoferrin obtained using the Superdex 200 10/300 GL column
Fig. 2 Evaluation of the resolution properties of the MonoS 5/50 GL
column used to separate bovine lactoferrin in a two-step purification. a
MonoS chromatography of DMV International lactoferrin (the collect-
ed fraction highlighted in gray bar). b Fraction obtained from the first
ion exchange separation was modified using the methods described in
experimental section to get iron-saturated and iron-depleted lactoferrin
forms. c Elution profiles of apo- and hololactoferrins from the MonoS
column from the second separation: apo-Lf (black), holo-Lf (red)
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in lactoferrin protein (the N-terminus of this protein has strong
cationic peptide regions) is the main driving force for electro-
static interactions. The degree of iron saturation, which proba-
bly alters lactoferrin pI and conformation, seems to be less
important for ion exchange chromatography.
Method for the estimation of iron saturation in lactoferrin
preparation
As mentioned before, employment of spectrophotometric
measurements as a simple and rapid method for the estima-
tion of iron content in the starting material as well as in the
processed samples might not yield reliable and accurate
results. This is mainly due to the high diversity of absorption
coefficients for apo- and holo-Lf that can be found in the
literature (see Table S1), which arise from the difficulty in
the preparation of standards. We have shown that chromato-
graphic separation between these two species is challenging
and that no satisfactory results were obtained. Furthermore,
most often, lactoferrin preparation is a mixture of various Lf
species (apo, holo, monoferric N-domain, and monoferric
C-domain forms), and using just one coefficient does not
reflect their complexity. To overcome the problems associ-
ated with spectrophotometric measurements, a calibration
curve for the estimation of iron content was prepared by
the combination of two analytical methods. ELISA was
employed for accurate and specific quantitation of Lf in
the samples and ICP-MS served as a method for determin-
ing iron content. We still used UV/VIS spectrophotometry
for the rapid and inexpensive screening of procedures lead-
ing to obtaining apo- and hololactoferrin preparations. Our
goal was to show the relationship between the obtained
ratios of A280/A466 (values that do not involve the applica-
tion of molar absorption coefficients) and precise iron con-
tent in Lf samples determined using ELISA/ICP-MS
tandem. The obtained data are presented in Fig. 3.
There is a nonlinear correlation between the measured
absorbance ratios and iron saturation levels calculated from
the values obtained with ELISA and ICP-MS measure-
ments. This can be explained by the vast difference between
the absorption coefficients for bands at 280 and 466 nm. The
obtained data imply the power relationship shown in Eq. 1
for which the best fit was achieved (Fig. 3).
A280
A466
¼ a iron saturationð Þb ð1Þ
where a ¼ 933:0 47; b ¼ 0:817 0:056
To our best knowledge, there have been no reports in the
literature enabling the utilization of the A280/A466 ratio for
the estimation of the iron content in lactoferrin preparation
in a wide range of saturation. Based on the proposed fitting,
the calculated value for 100 % hololactoferrin would be
approx. 22, which is in very good agreement with the value
of approx. 22 found for non-glycosylated human serum
transferrin [35]. It must be noted that very small differences
in the A280/A466 ratio for the highly saturated lactoferrin prep-
arations give a large change in the iron saturation quantity; the
inaccuracy of the calculated values can be as high as 10–15%.
The preparation of apolactoferrin with iron saturation below
2 % is characterized by the value of A280/A466 higher than
approx. 530. According to the results presented in this work, a
relatively large variation in the value of A280/A466 at very low
iron saturation gives only a small contribution to the changes
in iron content, while accuracy of the measurement of absor-
bance at 466 nm is decreasing. Thus, for the precise determi-
nation of iron content when saturation is below 2 %, the
application of ELISA/ICP-MS tandem is recommended. Iron
saturation for the bovine lactoferrin acquired from DMV
International calculated using the presented calibration curve
was found to be 7.72±0.97 %, while the two independent
measurements using ELISA and ICP-MS methods gave a
value of 10.2±0.2 %. Our results provide an effective method
for a quick and simple estimation of the iron saturation levels
in bovine lactoferrin preparations. However, if there is a need
for a very accurate determination of iron concentration, only
the application of ELISA/ICP-MS tandem can yield reliable
results.
Apolactoferrin preparation
In acidic solutions (pH below 5), lactoferrin eagerly adopts
more flexible and open conformation, which facilitates the
release of ferric ion [7, 43]. Following the literature recom-
mendation, we used citrate as an efficient mediator of iron
transport from transferrins [37]. The efficiency of iron re-
moval from Lf in citrate buffer was tested in a pH range of
2–5 (Fig. 4). Iron removal was carried out at room temper-
ature (approx. 20 °C) since it was found that this process is
slightly more efficient than at 4 °C. It is very likely that the
protein structure becomes more flexible with temperature,
which increases the probability of iron release. The optimal
Fig. 3 Correlation between the A280/A466 ratios and lactoferrin iron
saturation calculated from ELISA and ICP-MS measurements
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pH value for iron desaturation (obtaining <2 % of differic
lactoferrin) was ≤3.5. Previous publications show similar
results, which indicate that between pH 2 and 3, iron release
from lactoferrin reaches a plateau [31, 44]. It has been
shown that apolactoferrin, upon dialysis at pH 4, exhibits
iron saturation of 2–2.5 % [24, 31].
Once retaining the ability of efficient ferric ion binding by
the preparation of apolactoferrin, which is crucial, the apo-Lf
sample was saturated with iron according to the procedure
described in “Materials and methods.” We have observed an
effective resaturation with ferric ions for the protein sample
obtained at different pH values (Fig. 5), which supports the
assumption that apolactoferrin preparation does not affect
protein function—lactoferrin was proven to still be capable
of binding iron. Moreover, the CD spectra of the original
lactoferrin preparation and both apo- (pH 4) and holo-Lf do
not differ (ESM Fig. S1). Therefore, procedures leading to
obtaining those species of lactoferrin do not interrupt the
secondary structure of the protein and, most probably, do not
influence its functions.
It seems surprising that effective resaturation occurs also
for apolactoferrin preparations obtained at low pH 2.0 and 3.0.
It was shown that at these pH values, apo-Lf undergoes
thermal denaturation at room temperature [31], and one can
expect a substantially lower iron binding. However, we ob-
served a lower protein concentration for these conditions,
which suggests that, indeed, a part of the protein molecules
is denatured, but saturation with iron is only marginally
influenced. Therefore, the use of pH 4 provides a compromise
between preserving lactoferrin in a non-denatured state and
productive iron release from the protein.
Hololactoferrin preparation
To obtain iron-saturated lactoferrin, reaction of Lf with ferric
salts in neutral pH buffer (50 mM Tris–HCl, 150 mM NaCl,
pH 7.4) was utilized to provide optimal conditions for an
effective iron uptake. An iron chelator—nitrilotriacetic acid
Fig. 4 Effect of citrate buffer pH during dialysis at room temperature
on lactoferrin iron saturation. Data were obtained through the measure-
ment of absorbance ratio at 280 and 466 nm and converted to
lactoferrin iron saturation using the calibration curve described in
previous section
Fig. 5 Comparison of iron saturation of the original lactoferrin prepara-
tion (Lf DMV International) and hololactoferrins (holo-Lf) prepared by
resaturation with ferric ions of Lf DMV International as well as apo-Lf
obtained at various pH values
Fig. 6 Analysis of lactoferrin iron saturation under different condi-
tions. a Influence of the Lf/Fe/NTA ratio on the iron saturation process
carried out overnight. b Effect of saturation period on the overall
efficiency of this process. Lf/Fe/NTA was kept as 1:4:4
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(NTA) [45]—was employed to prevent unspecific binding of
ferric ions to protein molecules. NTA forms the 2:1 coordina-
tion complex with iron(III), Fe(NTA)2, with a pKML2 of
approx. 8 [46]. Therefore, it is a much weaker chelator than
the lactoferrin binding pocket, however strong enough to
shield the protein against iron binding in a nonspecific man-
ner. A few different ratios of protein/iron/NTA were used,
yielding comparable results measured by the percentage of
iron saturation of Lf (Fig. 6a). Only when the excess of NTA
was present in the solution was a noticeable decrease in the
iron saturation of Lf observed.Nevertheless, lactoferrin affinity
for iron is strong enough to sequester iron from the Fe(NTA)2
complex. For all following procedures, the protein/iron/NTA
ratio of 1:4:4 was utilized. Similar conditions were also applied
by other researchers [8, 24]. The binding of iron by lactoferrin
involves the coordination of a synergistic carbonate anion that
is coordinated in a bidentate manner [47]. Previous studies
have proved that other ions such as citrate or oxalate can also
substitute carbonate ion [48]. Our studies have shown that in
the absence of the external added sodium bicarbonate as well
as in its presence in the range 0.1–1.0 M, the extent of iron
saturation is very similar (results not shown). Even without the
addition of sodium bicarbonate, CO3
2− can still be employed
as a synergistic ion due to the hydration of CO2 dissolved in
aqueous solution. The engagement of nitrilotriacetate in coor-
dination of iron in the lactoferrin pocket is unlikely, as shown
by other studies [49].
Another factor examined was the time required for the full
saturation of the iron binding pockets of lactoferrin. The
change in the color of native lactoferrin was observed imme-
diately upon the addition of a mixture of ferric salt and NTA.
The undergoing reaction was examined employing stopped-
flow spectroscopic measurements. All obtained results point to
a fast and effective process of Lf iron saturation, reaching its
plateau after approx. 10 s (ESM Fig. S2). This finding is in
good agreement with previously reported data, which
suggests that most of the iron uptake by lactoferrin
occurs within a few seconds, followed by a very slow
reaction giving only small changes in absorption at
466 nm [50]. In order to obtain a fully saturated protein,
prolonged saturation periods were tested. However, no
significant difference was observed as a result of the applica-
tion of longer timescales (Fig. 6b). These observations con-
firm that lactoferrin acts as a thermodynamically and
kinetically efficient chelator for iron(III) ion.
Despite changing the saturation conditions, the lowest
ratio for A280/466 was 26, which corresponds to approx.
80 % of differic lactoferrin form. In the literature, an absor-
bance ratio between 27 and 29 was accepted as a fully
saturated lactoferrin [51]. However, our findings point out
that a ratio of 22 must be reached in order to obtain 100 %
saturation, in agreement with other studies performed for
transferrin [35].
Conclusions
We proposed in this article the simple, rapid, and high-
throughput method for obtaining a high-quality, substantially
pure, structurally intact, and biologically functional samples of
lactoferrin with its iron content determined. The suggested
protocol can be employed for further studies aimed at verifi-
cation of the biological/medicinal properties of the apo and
holo forms of lactoferrin. Apolactoferrin has been attributed
with multifunctional properties, including its potential to act
as a promising antibacterial agent that could efficiently de-
prive bacteria of iron and inhibit their growth. However, it
seems essential to retain its ability to bind ferric ions with high
affinity—use of pH 4 seems a fine compromise between
preserving lactoferrin function and obtaining its apo formwith
iron saturation levels of approx. 2 %. Nevertheless, whether
apolactoferrin prepared in such a manner is truly an iron-
depleted form for bacterial pathogens is an interesting ques-
tion requiring further investigation.
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